Tamara G. Amstislavskaya

Dr. Tamara G. Amstislavskaya

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in Hormones and Behavior
Verified
Journal Article
Closed access
TATamara G. Amstislavskaya
Tamara G. Amstislavskaya
NPNina K. Popova
Nina K. Popova

18 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Maria A TikhonovaMaria A Tikhonova
Maria A Tikhonova
OSOlesya Shoeva
Olesya Shoeva
MTMichael V. Tenditnik
Michael V. Tenditnik
MOMarina V. Ovsyukova
Marina V. Ovsyukova
AAAnna A. Akopyan
Anna A. Akopyan
Elena KhlestkinaElena Khlestkina
Elena Khlestkina
Functional foods enriched with plant polyphenols and anthocyanins in particular attract special attention due to multiple beneficial bioactive properties of the latter. We evaluated the effects of a grain diet rich in anthocyanins in a mouse model of Alzheimer’s disease induced by amyloid-beta (Aβ) and a transgenic mouse model of Parkinson’s disease (PD) with overexpression of human alpha-synuclein. The mice were kept at a diet that consisted of the wheat grain of near isogenic lines differing in anthocyanin content for five–six months. The anthocyanin-rich diet was safe and possessed positive effects on cognitive function. Anthocyanins prevented deficits in working memory induced by Aβ or a long-term grain mono-diet; they partially reversed episodic memory alterations. Both types of grain diets prolonged memory extinction and rescued its facilitation in the PD model. The dynamics of the extinction in the group fed with the anthocyanin-rich wheat was closer to that in a group of wild-type mice given standard chow. The anthocyanin-rich diet reduced alpha-synuclein accumulation and modulated microglial response in the brain of the transgenic mice including the elevated expression of arginase1 that marks M2 microglia. Thus, anthocyanin-rich wheat is suggested as a promising source of functional nutrition at the early stages of neurodegenerative disorders.

1 July 2017 in Behavioural Brain Research
Verified
Journal Article
Closed access
Maria A TikhonovaMaria A Tikhonova
Maria A Tikhonova
SHShih-Chun Ho
Shih-Chun Ho
AAAnna A. Akopyan
Anna A. Akopyan
NKNATALIYA G KOLOSOVA
NATALIYA G KOLOSOVA
JWJun-Cheng Weng
Jun-Cheng Weng
YHYing-Jui Ho
Ying-Jui Ho

21 May 2022 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
APAlexander B. Pupyshev
Alexander B. Pupyshev
VBVictor M. Belichenko
Victor M. Belichenko
MTMichael V. Tenditnik
Michael V. Tenditnik
ABAlim A. Bashirzade
Alim A. Bashirzade
NDNina I. Dubrovina
Nina I. Dubrovina
Maria A TikhonovaMaria A Tikhonova
Maria A Tikhonova

4 February 2022 in Toxics
Verified
Journal Article
Open access
PDF file
Alim BashirzadeAlim Bashirzade
Alim Bashirzade
SCSergey Cheresiz
Sergey Cheresiz
ABAlisa S. Belova
Alisa S. Belova
ADAlexey Vitalievich Drobkov
Alexey Vitalievich Drobkov
AKAnastasiia Korotaeva
Anastasiia Korotaeva
AKAllan V. Kalueff
Allan V. Kalueff
The zebrafish is a promising model species in biomedical research, including neurotoxicology and neuroactive drug screening. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) evokes degeneration of dopaminergic neurons and is commonly used to model Parkinson’s disease (PD) in laboratory animals, including zebrafish. However, cognitive phenotypes in MPTP-evoked experimental PD models remain poorly understood. Here, we established an LD50 (292 mg/kg) for intraperitoneal MPTP administration in adult zebrafish, and report impaired spatial working memory (poorer spontaneous alternation in the Y-maze) in a PD model utilizing fish treated with 200 µg of this agent. In addition to conventional behavioral analyses, we also employed artificial intelligence (AI)-based approaches to independently and without bias characterize MPTP effects on zebrafish behavior during the Y-maze test. These analyses yielded a distinct cluster for 200-μg MPTP (vs. other) groups, suggesting that high-dose MPTP produced distinct, computationally detectable patterns of zebrafish swimming. Collectively, these findings support MPTP treatment in adult zebrafish as a late-stage experimental PD model with overt cognitive phenotypes.

27 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
Tatiana A. Alexandrovna KorolenkoTatiana A. Alexandrovna Korolenko
Tatiana A. Alexandrovna Korolenko
NDNina I. Dubrovina
Nina I. Dubrovina
MOMarina V. Ovsyukova
Marina V. Ovsyukova
NBNataliya Bgatova
Nataliya Bgatova
MTMichael V. Tenditnik
Michael V. Tenditnik
TATamara G. Amstislavskaya
Tamara G. Amstislavskaya
Autophagy attenuation has been found in neurodegenerative diseases, aging, diabetes mellitus, and atherosclerosis. In experimental models of neurodegenerative diseases, the correction of autophagy in the brain reverses neuronal and behavioral deficits and hence seems to be a promising therapy for neuropathologies. Our aim was to study the effect of an autophagy inducer, trehalose, on brain autophagy and behavior in a genetic model of diabetes with signs of neuronal damage (db/db mice). A 2% trehalose solution was administered as drinking water during 24 days of the experiment. Expressions of markers of autophagy (LC3-II), neuroinflammation (IBA1), redox state (NOS), and neuronal density (NeuN) in the brain were assessed by immunohistochemical analysis. For behavioral phenotyping, the open field, elevated plus-maze, tail suspension, pre-pulse inhibition, and passive avoidance tests were used. Trehalose caused a slight reduction in increased blood glucose concentration, considerable autophagy activation, and a decrease in the neuroinflammatory response in the brain along with improvements of exploration, locomotor activity, anxiety, depressive-like behavior, and fear learning and memory in db/db mice. Trehalose exerted some beneficial peripheral and systemic effects and partially reversed behavioral alterations in db/db mice. Thus, trehalose as an inducer of mTOR-independent autophagy is effective at alleviating neuronal and behavioral disturbances accompanying experimental diabetes.